Recurrence Risk Following Percutaneous Transthoracic Needle Biopsy in Patients Undergoing Sublobar Resection for Stage I Lung Cancer.
IF 15.2
1区 医学
Q1 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Yura Ahn, Geun Dong Lee, SeHoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Kyung-Hyun Do, Joon Beom Seo, Jae Kwang Yun, Sang Min Lee
求助PDF
{"title":"Recurrence Risk Following Percutaneous Transthoracic Needle Biopsy in Patients Undergoing Sublobar Resection for Stage I Lung Cancer.","authors":"Yura Ahn, Geun Dong Lee, SeHoon Choi, Hyeong Ryul Kim, Yong-Hee Kim, Dong Kwan Kim, Seung-Il Park, Kyung-Hyun Do, Joon Beom Seo, Jae Kwang Yun, Sang Min Lee","doi":"10.1148/radiol.250415","DOIUrl":null,"url":null,"abstract":"<p><p>Background Whether preoperative percutaneous transthoracic needle biopsy (PTNB) increases the risk of local-regional recurrence in the context of sublobar resection remains unclear. Purpose To investigate the associations of PTNB with recurrence and overall survival (OS) after sublobar resection in patients with stage I non-small cell lung cancer. Materials and Methods Patients who underwent sublobar resection for confirmed pathologic stage I non-small cell lung cancer (tumor size ≤3 cm) between January 2010 and December 2021 were included in this retrospective study. Propensity score matching (PSM) using 12 clinical and patient confounding factors was performed to balance patients who underwent PTNB with those who did not at a 1:1 ratio. The outcomes evaluated were freedom from overall recurrence, specific recurrence patterns (local-regional, distant, remnant lung, and ipsilateral pleural recurrence), and OS. Cox proportional hazards regression was used to determine the effect of PTNB on these outcomes. Results Among the 2026 patients included (mean age, 62.9 years ± 9.6 [SD]; 989 male patients [48.8%]), 783 (38.6%) underwent PTNB. At follow-up, 192 patients (9.5%) had recurrence: 83 patients had local-regional recurrence, 81 had distant recurrence, and 28 showed both types of recurrence. In the PSM group (<i>n</i> = 1144), PTNB was associated with a greater risk of overall recurrence (hazard ratio [HR], 1.49; 95% CI: 1.03, 2.17; <i>P</i> = .03) and local-regional recurrence (HR, 2.32; 95% CI: 1.25, 4.31; <i>P</i> = .008), without evidence for distant recurrence (<i>P</i> = .29). Among local-regional recurrences, PTNB was linked to an increased risk of remnant lung recurrence (HR, 2.07; 95% CI: 1.08, 3.97; <i>P</i> = .03) but not to ipsilateral pleural recurrence (HR, 1.13; 95% CI: 0.47, 2.73; <i>P</i> = .79). There was no evidence of an association between PTNB and OS (HR, 1.27; 95% CI: 0.89, 1.83; <i>P</i> = .19). Conclusion Preoperative PTNB was associated with an increased risk of local-regional recurrence, particularly in the remnant lung, in patients with stage I non-small cell lung cancer who underwent sublobar resection. <i>Supplemental material is available for this article.</i> © RSNA, 2025 See also the editorial by Sohn and Dao in this issue.</p>","PeriodicalId":20896,"journal":{"name":"Radiology","volume":"317 1","pages":"e250415"},"PeriodicalIF":15.2000,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Radiology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1148/radiol.250415","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
引用
批量引用
Abstract
Background Whether preoperative percutaneous transthoracic needle biopsy (PTNB) increases the risk of local-regional recurrence in the context of sublobar resection remains unclear. Purpose To investigate the associations of PTNB with recurrence and overall survival (OS) after sublobar resection in patients with stage I non-small cell lung cancer. Materials and Methods Patients who underwent sublobar resection for confirmed pathologic stage I non-small cell lung cancer (tumor size ≤3 cm) between January 2010 and December 2021 were included in this retrospective study. Propensity score matching (PSM) using 12 clinical and patient confounding factors was performed to balance patients who underwent PTNB with those who did not at a 1:1 ratio. The outcomes evaluated were freedom from overall recurrence, specific recurrence patterns (local-regional, distant, remnant lung, and ipsilateral pleural recurrence), and OS. Cox proportional hazards regression was used to determine the effect of PTNB on these outcomes. Results Among the 2026 patients included (mean age, 62.9 years ± 9.6 [SD]; 989 male patients [48.8%]), 783 (38.6%) underwent PTNB. At follow-up, 192 patients (9.5%) had recurrence: 83 patients had local-regional recurrence, 81 had distant recurrence, and 28 showed both types of recurrence. In the PSM group (n = 1144), PTNB was associated with a greater risk of overall recurrence (hazard ratio [HR], 1.49; 95% CI: 1.03, 2.17; P = .03) and local-regional recurrence (HR, 2.32; 95% CI: 1.25, 4.31; P = .008), without evidence for distant recurrence (P = .29). Among local-regional recurrences, PTNB was linked to an increased risk of remnant lung recurrence (HR, 2.07; 95% CI: 1.08, 3.97; P = .03) but not to ipsilateral pleural recurrence (HR, 1.13; 95% CI: 0.47, 2.73; P = .79). There was no evidence of an association between PTNB and OS (HR, 1.27; 95% CI: 0.89, 1.83; P = .19). Conclusion Preoperative PTNB was associated with an increased risk of local-regional recurrence, particularly in the remnant lung, in patients with stage I non-small cell lung cancer who underwent sublobar resection. Supplemental material is available for this article. © RSNA, 2025 See also the editorial by Sohn and Dao in this issue.
I期肺癌行肺叶下切除术患者经皮经胸穿刺活检后复发风险。
背景:术前经皮经胸穿刺活检(PTNB)是否会增加叶下切除术中局部区域复发的风险尚不清楚。目的探讨PTNB与I期非小细胞肺癌肺叶下切除术后复发及总生存期(OS)的关系。材料与方法本研究纳入2010年1月至2021年12月间因病理证实的I期非小细胞肺癌(肿瘤大小≤3cm)行肺叶下切除术的患者。使用12个临床和患者混杂因素进行倾向评分匹配(PSM),以1:1的比例平衡接受PTNB的患者和未接受PTNB的患者。评估的结果是总体复发、特定复发模式(局部、局部、残肺和同侧胸膜复发)和OS的自由。采用Cox比例风险回归来确定PTNB对这些结果的影响。结果纳入的2026例患者(平均年龄62.9岁±9.6 [SD],男性989例(48.8%))中,783例(38.6%)行PTNB。随访时复发192例(9.5%),局部局部复发83例,远处复发81例,两种复发28例。在PSM组(n = 1144)中,PTNB与总体复发风险(风险比[HR], 1.49; 95% CI: 1.03, 2.17; P = .03)和局部-区域复发(风险比[HR], 2.32; 95% CI: 1.25, 4.31; P = .008)相关,无远处复发的证据(P = .29)。在局部-区域复发中,PTNB与残肺复发风险增加相关(HR, 2.07; 95% CI: 1.08, 3.97; P = 0.03),但与同侧胸膜复发无关(HR, 1.13; 95% CI: 0.47, 2.73; P = 0.79)。没有证据表明PTNB与OS之间存在关联(HR, 1.27; 95% CI: 0.89, 1.83; P = 0.19)。结论术前PTNB与局部区域复发风险增加有关,特别是在残肺中,对于接受叶下切除术的I期非小细胞肺癌患者。本文有补充材料。©RSNA, 2025另见Sohn和Dao在本期的社论。
本文章由计算机程序翻译,如有差异,请以英文原文为准。